News from the Visegrád Countries - Czech Republic, Poland, Slovakia and Hungary

Two abstracts from the 32nd International Congress of Clinical Neurophysiology (ICCN) of the IFCN, September 4-8, 2022, Geneva, Switzerland.

The authors are neurologists at the National Institute of Mental Health, Neurology, and Neurosurgery, Budapest.

TH-284. Dysautonomia in patients recovered from COVID-19, 2022, Győrfi et al

Introduction: Following acute COVID–19 infection several persistent symptoms (sweating dysfunctions, palpitations, orthostatic intolerance) might be related to immune-mediated disruption of the autonomic nervous system. We present the results of small fiber examination in patients with post-COVID syndrome.

Methods: In our database, we enrolled 32 patients who recovered from COVID-19. After recording the demographic data and post-COVID symptoms, the participants completed the Composite Autonomic Symptom Scale – 31 (COMPASS-31) questionnaire, followed by a complete neurological examination. Sudomotor function was assessed using the Vitalscan Sudocheck machine, while the cardiac function was recorded with Wiwe device.

Results: Dizziness, fatigue, “brain fog,” palpitations, and numbness were the most common symptoms. None of the patients presented any focal signs on neurological examination. The participants were classified into four groups based on neurophysiological findings: patients in group A (n=8, 25%) showed impaired sympathetic skin response, defined as bioelectrical conductivity < 60 µS. Decreased quantitative sudomotor axon reflex test, established as low sweat activity reflex was noted in 5 (16%) patients (group B). Group C (n=14, 44%) consisted of cases with impaired heart rate variability, established as a reduction in any of the time domain indices (SDNN, PNN50, and RMSSD). Group D included 7 (22%) post-COVID patients, who did not present any functional abnormality on the above-mentioned neurophysiological modalities.

Despite the small sample size, group B showed the highest COMPASS-31 total score (12.5/100) compared to the other groups (group A: 9/100, group B:10/100). Among all the cases, group B patients presented the highest scores in COMPASS-31 pupillomotor subdomain assessment (4/12).

Group A presented lower SDNN and RMSSD indices compared to patients without sudomotor dysfunction (only the RMSSD data showed a statistically significant difference; p< 0,05). Despite our expectations, the scores of the COMPASS-31 secretomotor subdomain in Group A did not show any significant difference compared to the other groups. Examining the COMPASS-31 subdomains in neurophysiologically intact cases in group D, we found that the highest scores pertain to the gastrointestinal subdomain.

Conclusion: Dysautonomia is becoming more widely evident as a chronic consequence of COVID infection. The COMPASS-31 questionnaire showed a sensitivity of 100% and a positive predictive value of 80%, but we noticed several inconsistencies. The discrepancy between the sub-scores of the small fiber questionnaire and the results of the neuropsychological examination address the need for further extended autonomic studies.


TH-285. Autonomic nervous system dysfunction in long-COVID patients, 2022, Győrfi et al

Introduction: Accumulating evidence supports that 6 months after COVID-19 almost 80% of the patients present residual neurological manifestations. Some of these symptoms may be associated with autonomic nervous system (ANS) damage. Several possible mechanisms have been proposed, including the detrimental effect of the virus-induced cytokine storm, direct viral spread into the nervous system, and an immune-mediated autoimmune mechanism. The extent of ANS involvement and exact pathological locations are unknown.

Methods: The aim of our study was to characterize the peripheral autonomic nervous system involvement in post-COVID patients. We compared the outcomes of neurological and neurophysiological examinations with the results of asymptomatic control subjects.

In our study, we studied 33 patients (20 women, mean age: 39 ± 8 years) with post-COVID, transient or persistent neurocognitive and/or autonomic nervous system symptoms and 8 (4 women, 29 ± 5 years) control subjects. After detailed neurological examination, the ANS functional assessment was performed with Quantitative Sudomotor Axon Reflex Test (QSART) and Sudomotor Sympathetic Skin Response (SSR) using Vitalscan SudoCheck + machine. Heart rate variability (HRV) was determined using a WIWE instrument.

Results: Focal neurological signs were not found in any of the patients. Regarding the autonomic nervous system studies, SSR measurement was the most sensitive in our population: we found abnormal SSR values in 8/33 of our post-COVID patient group (24%), while we did not find any abnormal SSR values in the control group. These 8 post-COVID patients showed moderate to severe (bioelectrical skin conductivity: 24.3-59.4 µS) ANS dysfunction. During the one-minute HRV measurement, we assessed the standard deviation of heart rate variability (SDNN) and the root mean square of the RR intervals (RMSSD). Abnormally low values were measured in 14/33 patients (42%) (SDNN mean: 18-23 ms, RMSSD mean: 13-14 ms).

Conclusion: In our study, different neurophysiological examination modalities confirmed ANS involvement in post-COVID patients. The extent of cardiovascular autonomic involvement (42%) was higher than sudomotor dysfunction (24%). These ratios significantly exceed the results of similar measurements in the age-matched control group. We suggest that the dysautonomia profile might explain the persistent symptoms after COVID-19.

Edit: I've just realized these are from 2022, not this year, so edited the years accordingly.
 
Last edited:
HUF 3 billion research is being launched in Szeged on the relationship between infectious and immunological diseases (Google translated article)

"Among the diseases selected for detailed analysis are the post-Covid syndrome, an inflammatory autoimmune disease affecting the central nervous system, multiple sclerosis, chronic fatigue syndrome, an autoimmune disease with inflammatory changes in the joints, rheumatoid arthritis, chronic autoimmune disease that attacks various organs of the body disease, systemic lupus erythematosus and inflammatory bowel diseases."

I need to run, so I'm not able to take a closer look right now, but this looks interesting in a country where the highlighted diseases are rarely even talked about.
 
So: after taking a bit better look: This is part of the ID-DarkMatter-NCD project, coordinated by Thomas Vogl from the Medical University of Vienna, Austria and the Biological Research Centre from Szeged (Hungary) is part of the project. The latter's systemic immunology research group is responsible for the genetic analysis of the 6000 participants.

From the Hungarian research centre's page: "With the help of modern multi-omic methods and genetic tests (HLA molecule and immune receptor genotyping), the team creates a detailed immunological profile of each patient, which allows them to get a comprehensive and detailed picture of the development of diseases."

Here you can read about this in English on the page of the Medical University of Vienna. There are a lot of partners:

Details of the project
ID-DarkMatter-NCD will run as part of the EU Framework Programme for Research and Innovation "Horizon Health" (HORIZON-HLTH-2023-DISEASE-03).
• Total project: €8.4 million
• MedUni Vienna's share: €2.5 million
• Consortium: 12 partners
• Duration: 60 months
• MedUni Vienna participants: Center for Cancer Research (Thomas Vogl, coordinator), Division of Rheumatology (Michael Bonelli)

Project partners:
Medical University of Vienna (Austria)
Karolinska Institute (Sweden)
Sorbonne University (France)
University Medical Center Groningen (Netherlands)
Leiden University Medical Center (Netherlands)
Eutema Research Services (Austria)
Vall d'Hebron Research Institute (Spain)
Biological Research Center Szeged (Hungary)
Christian-Albrechts-Universitaet Zu Kiel (Germany)
Assistance Publique Hopitaux De Paris (France)
Universitatsklinikum Schleswig-Holstein (Germany)
An associated partner in Switzerland has additional funding of approximately €1.2 million:
University of Basel

There is supposed to be a website which doesn't seem to work yet.

Is this of interest to you @Andy and @Simon M ? Maybe you are already aware of this project but I'm just putting all this out here in case you would like to reach out to these researchers because of the genetic part.
 
Thanks Wyva, I'll pass details on to the team. Here are further details about the project.

Abstract
While it is known that post-COVID-19-condition (PCC) is caused by SARS-CoV-2 infection, for most other immune-related noncommunicable diseases (IR-NCDs), no such infectious disease (ID) triggers have been identified (yet). Many IDs exist that could potentially cause IR-NCDs, however these microbes have large genomes encoding many antigens possibly associated with IR-NCDs. Given that it is challenging to measure all these 100,000s of structures in parallel, they represent the dark matter of ID-immune interactions. Furthermore, exposure to an ID alone typically does not trigger development of an IR-NCD: For example only a subset of patients infected with SARS-CoV-2 develop PCC. So, genetic- and environmental aspects also affect the onset of IR-NCDs, but the exact factors are unknown for most IR-NCDs.

Here, we aim to 1.) identify IDs triggering IR-NCDs by screening for antibody responses against 600,000 ID antigens, and 2.) to disentangle environmental and genetic factors affecting the transition from IDs to IR-NCDs. We will combine novel multi-omics approaches and technologies for personalized genotyping of HLA and adaptive immune receptor genes to deeply profile 6,000 patients of six IR-NCDs (PCC, multiple sclerosis, ME/CFS, rheumatoid arthritis, lupus, IBD) to identify novel biomarkers and disease mechanisms.

This project will represent the largest and most deeply profiled systematic study of multiple IR-NCDs with layered datasets allowing for comparative analyses yielding insights into shared mechanisms and potential differences in the role of IDs between IR-NCDs. Building on associations identified from population scale and clinical cohorts, we will demonstrate causality in gnotobiotic mouse models, and leverage machine learning (ML) algorithms to predict disease progression and response to treatment. The combination of novel assays with ML represents a broadly applicable pipeline that can be used for studying the interplay of any other IDs/ IR-NCDs.

https://ec.europa.eu/info/funding-t...42/project/101136582/program/43108390/details
 
Thanks for posting @Wyva and @Andy

I think they got funding from the Horizon Europe call 'Relationship between infections and non-communicable diseases'. The European ME Coalition (EMEC) tried to highlighted this call as a potential funding source for ME/CFS research. Great to hear that this project by Vogl got funded and that ME/CFS will indeed be included.

To clarify: I don't think the EMEC website info had anything to do with the application and consortium. This call is also different from the one EMEC lobbied for, namely the one on under-researched high-burden diseases (where review is still ongoing).
 
This is great to see. It does feel like a real missed opportunity that Sjogren’s disease is not being included as one of the autoimmune diseases, given it is one of the closest to post-viral illnesses and post-Covid, with respect to its ability to trigger things like autonomic nervous system dysfunction and small fibre neuropathy, both of which are being seen in post-Covid (Sjögren’s is second known leading cause of neuropathy after diabetes. Many neurological Sjögren’s patients do not present with dryness and are seronegative. They are often misdiagnosed with ME, fibromyalgia, IBS POTs etc.,… profiling this type of Sjögren’s patient would be well worth doing!
 
What is covid doing in the brain?

Just recently there was an event in Hungary called the Brain Research Week, where the general public could attend talks by researchers about various brain-related topics. The effects of covid on the brain was one of these topics and the lectures of two researchers, Imola Wilhelm (Institute of Biophysics, Biological Research Center) and Ádám Dénes (Neuroimmunology Research Group, Experimental Medical Research Institute), were detailed in the article above. Ádám Dénes might sound familiar to some of you as I have mentioned him a couple of times, for example here. ME/CFS is not mentioned.

It is quite a long article, translated by ChatGPT. If anything sound too confusing, let me know:

"How do the brain and Covid come together?" – poses the question Imola Wilhelm, the scientific head researcher of the Biophysics Institute of the Szeged Biological Research Center, at the Brain Research Week event in Szeged, then immediately answers: we now know that Covid not only affects the respiratory tract but also the brain.

Wilhelm marginally deals with Covid research, using biophysical methods to examine how coronavirus proteins can bind to receptors on the blood-brain barrier cells. Since he studies the blood-brain barrier, he examined it in the context of Covid in his presentation.

Like a zipper in the brain
"When the disease starts, brain symptoms develop rarely, in about one to one and a half percent of cases, which can vary according to age. In younger ages, primarily meningitis, encephalitis, or epilepsy seizures develop. In older ages, stroke and cerebral ischemic symptoms are more typical," he says.

Science now knows more and more about long Covid, when symptoms appear more than three months after the disease's onset, often affecting the brain, accompanied by persistent fatigue, lethargy, insomnia, but may also include forgetfulness, concentration problems, and psychological symptoms. Loss of smell also relates to the brain, indicating involvement of the olfactory center. One of the most severe conditions of long Covid is called "brain fog," characterized by cognitive, concentration, and memory problems.

But how does Covid enter the brain? According to the researcher, one possibility is through the bloodstream. The brain is highly vascularized, meaning it has many blood vessels and a dense vascular network. "These capillaries function a bit differently than capillaries in other organs; they form the blood-brain barrier," he says.

The cells lining the brain capillaries are called brain endothelial cells. These cells acquire specific properties, barrier properties, in response to other cells present there. Since nutrient delivery occurs at the capillary level, it's important for these capillaries to be permeable. However, the cells here also need to form a barrier to protect the nervous system from harmful substances circulating in the blood.

That's why endothelial cells are tightly connected, "like a zipper that doesn't even let ions pass through. Practically, this means that if we tried to physically separate two endothelial cells from each other, they would most likely not break apart where they are connected, but one of the cells would split in half instead."

The brain cannot be completely isolated from the outside world
The blood-brain barrier works in multiple steps. Efflux transporters located in the membranes facing the blood of endothelial cells, for example, have the role of pumping back substances that cannot pass between cells, hence they try to pass through the cells. Besides harmful substances, sometimes even drug molecules are pumped back since endothelial cells do not recognize them evolutionarily.

There are neurotropic viruses capable of entering, such as the rabies virus, which travels along nerves to the brain. However, according to Wilhelm, some viruses can also pass through the blood-brain barrier. They mostly have three methods for this. One is by opening the blood-brain barrier; the second is by passing through an endothelial cell, and the third is "the specific Trojan horse method, where they exploit other cells that carry them. Primarily immune cells where they hide." The Ebola virus uses the first method, the Zika virus uses the second, while, for example, HIV can pass through with the Trojan horse method.

Through the bloodstream, viruses can also reach the region in the walls of the brain ventricles called the choroid plexus. There, they can pass through the vessels, but there's another barrier system, the blood-cerebrospinal fluid barrier, which they may bypass. The third possibility is that viruses travel along nerves, nerve fibers.

"What does our virus, SARS-CoV-2, use?" Wilhelm poses the question. The answer is, theoretically, all the mentioned routes, as its proteins can enter the cells of the blood-brain barrier and the blood-cerebrospinal fluid barrier through receptors, from the optic nerve through the eye, but also from the nasal cavity or the trigeminal nerve from internal organs. However,

"the latest research shows that it's not so much the virus that primarily causes the neurological symptoms mentioned earlier, but for example, the opening of the blood-brain barrier,"

because this allows substances to enter the brain that have no business being there and can also cause inflammation.

"Samples taken from patients' plasma during Covid revealed an increase in inflammatory factors in the blood, especially in severe cases," says Wilhelm. Comparisons showed that in those patients where brain fog appeared during long Covid, much more inflammatory factors were present than in those where it did not. Research suggests that the cognitive and thinking disorders associated with long Covid are primarily due to the opening of the blood-brain barrier and the sustained systemic inflammatory reaction, not the presence of the virus itself in the brain.

A skilled servant in the Victorian world
"Maintaining the internal circulation of the brain requires the functioning of the blood-brain barrier, but also precise and continuous regulation of cerebral circulation," takes over Dénes Ádám, head of the Neuroimmunology Research Group at the Experimental Medical Research Institute, providing deeper insights into brain inflammatory processes and the development of neurological symptoms caused by Covid.

The brain comprises about two percent of the total body mass, but consumes twenty percent of circulating glucose and oxygen. "It requires a very complex mechanism to solve the issue of not allowing the circulating blood's substances and immune cells into the brain tissue from one side, but also continuously maintain this very intensive cerebral circulation."

The brain's functioning requires constant environmental stability because nerve cells are very sensitive to disturbances in the brain microenvironment. Moreover, they are vulnerable, so inflammatory cells should not be allowed in. "The brain has a main immune cell population called microglia.

It's like a very skilled servant in the Victorian world, capable of doing everything: serving tea, cleaning, cooking, and if it's in a bad mood, it can also poison the master's tea. We see this during inflammatory conditions."

If nerve cells die, they cannot be replaced, so it matters how regulated inflammation is in the brain. "It's not accidental that most neurological diseases have detectable inflammatory factors and changes in the state of microglia cells behind them," said Dénes Ádám.

The researcher and his team examine, among other things, how microglia cells communicate with nerve cells and brain blood vessels, "because they are not only very sensitive sensors to any changes happening in the brain, but also the main regulators of inflammatory processes." In brain inflammatory processes, microglia cells are always present as "conductors," and unfortunately, sometimes they get injured and cannot conduct the orchestra well.

They constantly "feel" the nerve cell membranes and reach back to those points where nerve cells release substances during their metabolism, which continuously regulate the connections of microglia cells.

If microglia becomes inflamed
"Each of these microglia cells is like an octopus, capable of establishing connections with numerous nerve cells and small vessels," so when inflammatory processes start in the brain, neighboring nerve cells and vessels will also detect it. According to Dénes Ádám, it was predictable that if a virus like Covid appears, there will be neurological symptoms:

either processes outside the nervous system cause inflammation affecting brain function, or the virus itself penetrates the brain.

It was visible that systemic inflammation started in Covid patients, often affecting the heart, kidneys, intestines, liver, besides acute viral infection in the lungs.

Since Covid affects numerous organs and their vessels, it can lead to multi-organ inflammation and multi-organ infection. By this point, the virus is not only in the lungs but also in the liver, spleen, and even in the brain. The amount of detectable virus in the brain correlates with how much is present in the peripheral organs, but Covid can persist, even half to three-quarters of a year in the central nervous system if it wants to.

According to the researcher, in those patients who contracted Covid and had neurological symptoms, a small decrease in the volume of the cortical substance was observed, as well as circulation disorders. Microglia cells not only regulate the activity of nerve cells but also cerebral circulation, so circulation disorders may indicate their injury. Moreover, Covid-induced brain inflammation is most severe in the brainstem, the brain area playing a key role in regulating respiration and circulation.

It's no coincidence that many Covid patients show vegetative symptoms, cardiovascular disorders, arrhythmias. In this, a significant etiological factor seems to be that inflammatory changes and nerve injury occur in brain centers regulating vegetative and hormonal functions, and the disturbance of microglia cells is one of the central elements.

Through specific receptors, microglia cells communicate with nerve cells and vessels, regulating nerve cell activity and cerebral blood flow. In areas where brain inflammation occurs, over time, a key communication pathway of microglia cells with their environment, with which they can converse, is damaged, and the cells often die in inflammatory processes.

"It was assumed that if such events occur in a human brain, then disturbances in brain circulation and nerve networks will occur to an extremely large extent. It's no coincidence that EEG examinations show epileptoid activity and circulatory disorders in a significant portion of Covid patients during the acute phase. However, neurological symptoms will not necessarily correlate with the severity of lung infection.

Part of the reason behind this is that the blood vessels become inflamed, which are largely responsible for the blood supply to the autonomic centers. Then microglia cells crawl onto these vessels, and the inflammation coming from the vessel wall begins to damage them in some way.

If microglia show inflammatory changes, it can also happen that their cells start to nibble on the synapses of nerve cells, which are responsible for communication, or they may even eat the dying nerve cells. Certain sections of nerve cells are covered by myelin sheath, which is like insulation on a cable, ensuring normal nerve conduction. During Covid, if the myelin sheath comes into close contact with these microglia cells, it can be damaged, leading to serious impairment or even complete interruption of nerve conduction.

Heterogeneous symptoms

"It was assumed, based on our research data, that microglia detects the inflammatory substances of blood-derived immune cells, or the virus in them, after the vessel wall becomes inflamed, and brain inflammation develops, in which the change in the state of local microglia cells is an important factor. Inflammation greatly impairs nerve function in the given brain area and leads to nerve cell damage. Since vascular elements will inflame to different extents in various brain areas, neurological symptoms are also very heterogeneous," says Dénes.

For example, if a patient has sleep disorders but no cognitive dysfunction, it's assumed that the thalamus brain area, which plays a role in regulating sleep, may be inflamed, but not to the same extent as the cerebral cortex. Similarly, in patients with highly inflamed areas in the brainstem, local neural networks do not function well, and cerebral circulation is impaired, they may easily develop cardiovascular symptoms that greatly reduce their quality of life.

"For those with inflammation in memory-related areas of the cerebral cortex, memory disorders will occur, and there will be all kinds of combinations of heterogeneous symptoms depending on how much the given brain area was affected. The relationship between neurological symptoms and brain inflammatory changes is also confirmed by clinical imaging studies."
 
Just saw this on the Facebook page of the only Polish ME/CFS website I found a couple of years ago. It seemed to be dormant back then but this is today's FB post (Facebook translation):

After a while, the website me-csf.pl is back! We start a big-small comeback with the discovery of a YouTube channel by a chroniczynka - a patient who decided to spend her little energy exactly to make patients looking for information, diagnosis, or current recommendations of ME/CFS in Polish come across this easily accessible form which is a video-blog. So I encourage and invite you to subscribe, follow, listen and recommend - the protagonist does a lot of good work!
1f642.png

This is the website: me-cfs.pl

About the person running it:

My name is Ruth. I have been struggling with the disease ME/CFS for over 8 years. For balance, I also have a few more pleasant things: a good God in Heaven, a loving husband and son, a small group of people supporting me and my cat, Fryderyk. I'm still learning to reconcile my extroverted nature with my disability, which often doesn't work and ends with PEM. Raised on the Gospel and Dragon Ball, I believe that there is a way out of every situation and even if death comes, there is still resurrection.

Since November 2015, I have not known the feeling of health, but only in the summer of 2018 I found a diagnosis that was able to explain the multitude of symptoms that overwhelmed me in contrast to the results of laboratory tests in which I am a picture of health ;-). The time of searching for a diagnosis and the strong feeling of loneliness in contact with doctors made me want to create a place where people with similar experiences could find support, understanding and information about ME/CFS. Yes, welcome to this place – me-cfs.pl. My next dream is for knowledge about ME/CFS to be more common among doctors and society - I hope that my website will be able to contribute to this to some extent.

I am learning to accept my disability, but the feeling of loss and the change in perspective still surprise me. I often mix up words and when I recently managed to go to the store after a long break, I told my husband that "I'm glad I was on vacation yesterday." It was a Freudian mistake! It's still hard for me to believe that from the volcano of energy that I used to be, I have become a person who has to carefully consider whether she has the strength to wash the dishes. The lack of independence scares me, but I am learning to trust that God will meet my needs.

I am a psychologist by education. I do not have any special competences to run a medical website. In addition, I have a neurological disease, so if you think that you see an error on the website or in the translation, you are probably right. I try to write as best as I can, but I create the website using my humble resources (and my husband, who is an invaluable technical support). !), so if you have an idea on how to improve its quality and want to get involved in its implementation, please contact me.

Contact: rut[at]mecfs.pl
 
From the Polish ME/CFS website I follow:

Google translation:

Everything indicates that this summer (2024) we will happily see the first clinic in Poland dealing with the clinical diagnosis and management of ME/CFS as part of NIGRIR - Warsaw, Spartańska.​

The department is still being prepared to expand its activities, and patients who ultimately want to have professional diagnostics for ME/CFS performed there can also start preparing medical documentation to reduce the time and energy spent on diagnostics.

(...)

  • Help for ME/CFS patients that the clinic will be able to offer will include:
Clinical diagnosis for ME/CFS patients (including the possibility of performing a two-day stress test - which at the moment is one of the best available tests in the context of ME/CFS diagnosis that medicine provides us with);

Support in managing the symptoms of the disease based on current recommendations - including pacing (here called rehabilitation for formal reasons); psychological support .​

The full article
 
Hyperbaric Oxygen Therapy Conference in Hungary

Context: Nikolett Szolnoki, who offers this service, has been promoting HBOT as treatment for long covid in the media for a year or two now. The conference also took place where her private clinic operates.

Key points:
- They are (Szolnoki et al) doing long covid research in collaboration with the Medical University of Graz (Austria).
- They are working together with the University of Pécs, where a new course on oxygen therapy is starting for medical students, for the first time in Hungary.
- They are planning to work together with a county hospital in Croatia to do research in the future.
 
Some good news:

The governmental healthcare website Egészségvonal has updated its informational page on ME/CFS (written by the National Public Health Centre) after I sent them a letter pointing out in detail how much it differs from the current literature. Although I could still find a problematic part about treating symptoms with supplements, etc, it is now much better than the original version.

This is good news not only because journalists started to cite the original, poorly written Egészségvonal description in their articles about ME/CFS, but because there is barely anything available in Hungarian about ME/CFS that is factually correct and follows the current literature (apart from my website).

So I see this as a big win that a website that is probably seen as quite authoritative provides such information now. Here you can check out the version translated to English by Google. (For some reason Google only translates about half of the text for me, hopefully it works better for you.)
 
Last edited:
Here it is in English for those who have trouble with translating - google translation, hope it's ok.
It's very good Wyva, you have done a great job in helping them get important points across. I'm particularly impressed that the connection between Covid-19 and ME/CFS is there. Also the importance of avoiding PEM.
And basically no psychobehavioural nonsense!

Hungary is really fortunate to have you there.

Myalgic encephalomyelitis, also known as myalgic encephalomyelitis (chronic fatigue syndrome, ME/CFS), is a chronic disease with extreme fatigue and is extremely difficult to diagnose and affects multiple organ systems. The mechanism of its development is not fully understood, but it is usually linked to an infection (e.g. Epstein-Barr virus, COVID-19).

ME/CFS often has symptoms that cannot be confirmed by medical laboratory findings, it is characterized by chronic fatigue that cannot be explained by other things, worsening with activity, which can be associated with sleep disturbance, cognitive problems and many other symptoms. ME/CFS is more common in women, most commonly between the ages of 40 and 60, but can also occur in children and young people. The goal of treating ME/CFS is to alleviate symptoms because no specific drug or therapy is yet known.

Main symptoms of chronic fatigue syndrome
A disease-specific test for diagnosing ME/CFS does not currently exist. For this reason, it is very important to get to know the symptoms as accurately as possible (both on the part of the patient and the medical staff), since the primary task in diagnosing the disease is to clarify them and exclude other comorbidities.
The main symptoms of ME/CFS are as follows.
· Significant decline in activity in both work and private life. There is a large, previously unexperienced, chronic fatigue that cannot be explained by strenuous activity or other pathologies, and does not improve with rest.
· Post-exertional malaise (PEM). Symptoms worsen after physical or mental exertion. The extent of symptoms is excessive compared to the intensity of the exertion and often persists for days, weeks or even longer. It may not develop immediately, but later, between 12 and 48 hours after exertion, making it difficult to recognise the link between strain and PEM.
· Sleep disorders. Those affected do not feel more rested after sleep, and symptoms do not show improvement. The appearance of various sleep disorders is also common.
· Cognitive impairment.Symptoms may includememory impairment, disturbances in attention and concentration,speech disorder, difficulty thinking, difficulty solving complex tasks and inhibited psychomotor function (difficulty performing fine movements).
· Orthostatic intolerance.In an upright (sitting or standing) position, unpleasant physical symptoms occur, the most common of which are increased heart rate and blood pressure (Hypertonia). In addition, it is common forfainting,dizziness,headacheandnausea. Symptoms are typically relieved when lying down.

Non-diagnostic co-symptoms of ME/CFS may include:

· muscle pain, joint pain (without swelling or redness);
· headache (typically of a different pattern or intensity than previously experienced);
· swelling of lymph nodes (in the neck or armpit area);
· sore throat (often recurrent);
· gastrointestinal and urinary tract complaints;
· sensitivity to light, sound, smell, sensitivity to touch;
· shiveringnight sweats;
· visual disturbances;
· nausea;
· development of a new allergy or sensitivity (food intolerance,drug sensitivity, sensitivity to chemicals).


Types of chronic fatigue syndrome
ME/CFS can be classified into types based on disease severity. However, these are often difficult to determine, as each symptom can manifest itself in different severity and change over time.
ME/CFS types may be as follows.

· Mild ME/CFS. People suffering from a mild form are able to take care of themselves or do lighter household chores. Most people go to work or school, but it is common for them to give up leisure and social activities to avoid being overwhelmed. Many people are forced to work reduced hours, often taking time off or using weekends to cope with the rest of the week.

· Moderate ME/CFS. People suffering from moderate forms typically have reduced mobility, and everyday life activities are already difficult for them. They are typically unable to perform at work and study, they need 1-2 hours of rest in the afternoon after performing their everyday tasks. Night's sleep is typically of poor quality.

· Severe ME/CFS. People suffering from severe forms can only perform the simplest everyday tasks (e.g. maintaining individual hygiene: brushing their face and teeth). They have severe cognitive difficulties and their movements may be confined to a wheelchair. Often they can not leave the house, or only very rarely. They spend most of their time in bed, often extremely sensitive to light and sound.

· Very severe ME/CFS. Those affected by a very severe form are bedridden throughout the day and need constant supervision and care. They also need help with personal hygiene and food, and are also very sensitive to sensory stimuli. It may also happen that the patient is unable to swallow, so it is necessary to feed him with a tube.



Possible causes of chronic fatigue syndrome
The exact cause of chronic fatigue syndrome is unknown, but it is believed to be caused by a combination of factors.
The reasons involved in the development of ME/CFS may include the following.

· Infections. Common before illnessflu-likeexperiencing symptoms. Among others, the Epstein-Barr (see:Herpesvirus infections), a Ross River-, a Coxiella burnetii- (lásd:Q fever) and coronavirus infection have been linked to ME/CFS.

· Immune system changes. Altered immune functions cause the body to react differently to viral infections andstress. The dysfunction of the immune system is indicated by the fact that the syndrome is associated with an increase in inflammatory markers, an increase in cytokine production, a decrease in the function of NK cells and changes in T-cell activation can be detected.

· Change in the level of stress hormones. Levels of stress hormones (e.g. cortisol) affect immune function, digestion, energy expenditure and mood. Although ME/CFS often has cortisol levels below the population average – however, this is typically within limits and therefore has no diagnostic value, and no clear correlation can be established.

· Genetic causes. Although the exact genetic mutation is not known, which is clearly related to the development of the disease, in some cases family accumulation can be observed.


Diagnosis of chronic fatigue syndrome
Diagnosing ME/CFS is extremely difficult because its symptoms may overlap with many other diseases, and there is no test that can definitively detect it. For this reason, in many cases those affected are misdiagnosed or not diagnosed at all.

In recent years, several different sets of criteria have been developed that may differ slightly in exactly which symptoms are essential to make a diagnosis. Based on criteria established by the American Academy of Medicine in 2015, the appearance of the following symptoms is a diagnostic criterion: significant decrease in activity, PEM and sleep disorders (non-restful sleep). In addition, at least one of the symptoms of cognitive impairment and orthostatic intolerance is required.

Additional tests that may be used to diagnose ME/CFS may include:
· complete physical examination;
· examination of mental status using cognitive tests;
· 'tilt table test' means the study of changes in blood pressure and heart rate following a rapid change in a person's position (tilting the table from landscape to landscape);
· laboratory tests: liver and kidney function, inflammatory markers, HbA1c, thyroid panel, iron, etc.


Treatment of chronic fatigue syndrome
There is currently no approved drug or specific therapy for ME/CFS, treatment is limited to minimizing symptoms and improving quality of life. Treatment is completely individualised – this requires the patient, their family and healthcare staff to work closely together to determine which symptoms cause the greatest difficulty in everyday life.

During the treatment of the disease, most of the symptoms can be reduced by changing lifestyle factors, nutritional supplements and, if necessary, appropriate medication.

During the course of therapy, it is important to avoid PEM. The patient should be helped to keep his energy use within limits that do not yet trigger the PCA. Keep a diary of activities and symptoms for 1-2 weeks, after which they are evaluated together with your doctor looking for patterns in the symptoms (e.g. reading for an hour may trigger PEM after 48 hours, but 30 minutes may not cause it – in this case, the patient's maximum energy expenditure is 30 minutes for reading). Subsequently, the activities shall be adjusted so that they do not induce a PCA. This is often difficult, as patients tend to overwhelm themselves after a lighter, good day.


Prevention of chronic fatigue syndrome
Based on the current knowledge of medical science, ME/CFS cannot be prevented, so timely detection and symptomatic treatment play an important role in reducing symptoms.


Chronic fatigue syndrome in childhood
ME/CFS can also occur in children and adolescents. In them, the main symptoms are similar to those in adulthood, but more common is the presence of orthostatic intolerance, which is the symptom that most affects the quality of life in this age group. Joint and muscle pain is less common, but headaches and gastrointestinal symptoms are more common.

In school-age children, the disease often leads to neglect of school and other tasks. In many cases, parents may think of this as truancy, but the young people concerned begin to neglect not only the obligatory tasks, but also their own hobbies and social events!
 
Thank you. :) There are still some minor issues with it but it is much better than the original. Here is my letter to them pointing out the problems, so if anyone is interested, they can see what these problems were in the original version (ChatGPT translation, so far from perfect):

Dear Editorial Team of Healthline,

I am writing regarding the description of chronic fatigue syndrome on the Healthline website (https://egeszsegvonal.gov.hu/k/422-kronikus-faradtsag-szindroma.html), as unfortunately, it largely does not reflect the significantly updated literature on the disease in recent years and at times even confuses it with chronic fatigue symptoms. I have already brought to the attention of the Quality Improvement and Methodological Department within the Ministry of Interior the significantly changed literature, and after consulting with some sections of the Health Professional College, they have decided to prepare a consensus recommendation. I have posted their related letter here: https://mecfs.hu/2023/06/16/megerkezett-a-valasz-az-egeszsegugyi-szakmai-kollegium-tagozataitol/

I had also considered waiting for the consensus recommendation before writing to you. However, in the past few days and weeks, several online media outlets have published articles referring to the Healthline page on chronic fatigue syndrome (now known as ME/CFS in current literature), thus spreading scientifically outdated or incorrect information about the disease on a broader scale. Most recently, in Magyar Hírlap: https://www.magyarhirlap.hu/egeszseg/20240404-halalos-betegseghez-vezethet-a-kronikus-faradtsag

Unfortunately, this is not beneficial to anyone. I would like to demonstrate the numerous errors in the Healthline description, supported by sources, which include:

1. The name of the disease is now myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), as per the CDC, the redefining publication of the American Academy of Medicine in 2015, or the newly rewritten NICE guidelines in 2021, as well as the German informational sources and so forth. Therefore, it is not CFS.

2. Depression is not a characteristic symptom of the disease, at least not in any diagnostic criteria version I am aware of. It certainly does not appear in current criteria (Institute of Medicine, NICE).

3. The Healthline page still mentions the CDC's 1994 diagnostic criteria, known as Fukuda. I would like to point out that even the CDC's website has not included this for nearly 10 years, instead using the criteria established by the American Academy of Medicine during the redefinition of the disease in 2015. However, one could also refer to the NICE guidelines from 2021, which are extremely similar to these. The 1994 criteria are outdated compared to the newer, stricter criteria mentioned above, as they allowed individuals with other illnesses to meet them.

4. Due to the above, important symptoms such as the accurate description of post-exertional malaise (PEM) are missing. While there is mention of discomfort following exertion, key elements distinguishing it from simple exertional difficulty are absent: that PEM often occurs 12-48 hours after exertion and can persist for days, weeks, or even long term. It is also omitted that cognitive exertion can trigger it. There is no mention of orthostatic intolerance, which is also characteristic and not included in the criteria, nor other common symptoms such as light and sound sensitivity.

5. What sources does Healthline base the assertion that the mentioned exclusionary factors (depression, dementia, obesity, alcohol, etc.) cause a condition similar to ME/CFS? I am not aware of this, but I suspect it might be based on a study that confuses chronic fatigue with chronic fatigue syndrome. Many studies mistakenly refer to chronic fatigue as CFS, even though it does not meet the diagnostic criteria. I request that the description be based on studies not only mentioning CFS (whether erroneously or correctly) but clearly indicating, based on the diagnostic criteria used, that it is indeed ME/CFS, not chronic fatigue.

6. The same problem arises with the presumed triggering factors, likely based on literature confusing CFS with chronic fatigue rather than publications following ME/CFS diagnostic criteria. The cause of ME/CFS is unknown, and the theories only marginally align with the listed factors. Anemia, thyroid disease, tumors - these all cause chronic fatigue, but have nothing to do with ME/CFS. Virus infection is the only scientifically better-supported thing among these (but not meningitis!): The redefining statement of the American Academy of Medicine indicated, based on prospective longitudinal studies, that ME/CFS is supportedly associated with Epstein-Barr virus infection/mononucleosis, but probably also with certain other infections (though less studied). Therefore, if a specific example is needed, mentioning EBV would be most appropriate based on this. Including COVID as a triggering factor is very appropriate since many post-COVID patients meet the diagnostic criteria for ME/CFS, many of them exhibit PEM, which significantly distinguishes ME/CFS from other diseases.

7. The section on treatment options is very problematic. Firstly, cognitive behavioral therapy and graded exercise therapy have been rejected in recent years, beginning to be rejected by medical guidelines, as seen in the 2021 NICE guidelines or German recommendations, but the CDC removed them from their informational page years ago. The scientific basis for these therapies has been strongly questioned in recent years, and according to current recommendations, pacing is the most important thing. This means that patients should strive to use only as much energy as to not trigger PEM and thus not cause further deterioration of their condition. This is not a therapy; it simply aims to avoid discomfort. Therefore, the guidelines now emphasize that a patient should only exercise if they feel ready based on their condition (and exercise is not applicable as a treatment for the disease) and under the supervision of a doctor or specialist who is familiar with this condition. Similarly, cognitive behavioral therapy cannot be used to cure the disease but rather to help patients cope with the difficult life situation caused by chronic illness (so it is not meant to think oneself out of the illness).

These are primarily the issues I encounter at first glance, which do not provide information consistent with current international literature and guidelines (or are not related to this disease at all, but rather to chronic fatigue symptoms). My question is how can the Healthline website be improved to better follow current international literature and guidelines? It is important to take action to prevent the website and, consequently, the media from disseminating this misinformation to the public, as it can significantly worsen the situation for both the disease and the patients.

I understand that this is a larger task, so is it possible to at least post a short warning at the top of the article regarding the ongoing development of new scientific consensus on the disease and that the information provided here may not necessarily be accurate due to this? Even this would be a great help.

Thank you and regards,

Ágnes Szarvas

I also have to add that I have to credit S4ME as well for many things that I do. I have learnt an awful lot here about the science (or lack thereof), the methodology and also about how to do advocacy. Really it is the best resource for me, I'm really just copying and applying what others already said or did before me. 2-3 years ago I was much less confident in really having the knowledge base to be able to properly challenge doctors and academics but S4ME has taught me so much that it is not really an issue anymore (although I still need to learn a lot as I'm just a layperson).
 
From the Polish ME/CFS blog written by a patient:

SCIENTIFIC MEETING ON CHRONIC FATIGUE SYNDROME AT NIGRIR

Google translation:

NIGRiR is fully committed to preparing to work with ME/CFS patients. Therefore, on May 15 at 11:00 there will be a Scientific Meeting focused on Chronic Fatigue Syndrome - at which I will have the pleasure of being one of the speakers. Specialists and patients are invited to the event - it will be possible to participate online (which we know may be the only option for many patients!). The meeting will last about an hour, and then there will be time to ask questions about the disease itself, as well as issues related to the technical aspects of the diagnostic process that some patients are waiting for.

Online participation will be possible via Microsoft Teams - I will share the link closer to the event, and in the meantime I am posting the full text of the invitation below.​

NIGRIR is the National Institute of Geriatrics, Rheumatology and Rehabilitation in Warsaw. This is the same place that is setting up the first ME/CFS clinic in Poland, according to an earlier post on the blog.
 
This year ME/CFS Awareness Day was a little bit more in Hungary than in the past few years. First, one of my group members, Angelina Zakar created a dozen pictures with simple messages on them for 12th May to raise awareness. These were all variations of the same thing: eg. "I have ME/CFS", "my child has ME/CFS", a friend of mine has ME/CFS", "I stand with people with ME/CFS" etc etc, so everyone could share in their social media whichever was appropriate for their situation.

Then today, we had the first ME/CFS Awareness Day event (or any kind of ME/CFS event really) organized by an ME/CFS patient from my group called Mátyás Harangi, his wife Anna Harangi and the charity of their church. It was super lucky that the event took place super close to where I live (not on purpose, it was just coincidence).

So basically it was the three of us on the stage (and Adrián Molnár, a mental health professional was asking us some questions to guide the conversation). This is how it was structured: we watched a video with Hungarian subtitles about the disease (one by OMF, one by @Adam pwme , that old one with Charles Shepherd talking and one about severe ME/CFS made by a patient with severe ME/CFS). And after each video we had a short discussion.

It is in Hungarian so you won't understand it but just in case someone Hungarian who doesn't know my website stumbles upon this, here is the video.
 
Back
Top Bottom